bioterrorism

From Aaushi
Jump to navigation Jump to search
[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]

Introduction

The intentional release of pathogen(s) for the purpose of harming of killing civilians. [1]

Classification

* class A: greatest potential danger, easily disseminated or person to person spread, high mortality

* class B: less easily spread, fewer deaths

* class C: future ability to engineer for mass dissemination with substantial mortality

More general terms

Additional terms

References

  1. ↑ 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.
  2. ↑ Arnon SS, Schechter R, Inglesby TV Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001 Feb 28;285(8):1059-70. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11209178
  3. ↑ Borchardt SM, Ritger KA, Dworkin MS. Categorization, prioritization, and surveillance of potential bioterrorism agents. Infect Dis Clin North Am. 2006 Jun;20(2):213-25 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16762736
  4. ↑ Borio L, Inglesby T, Peters CJ, Schmaljohn AL et al Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002 May 8;287(18):2391-405. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11988060
  5. ↑ Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002 Apr 25;346(17):1300-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11923491
  6. ↑ Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001 Nov 29;345(22):1607-10 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11704685
  7. ↑ Dennis DT, Inglesby TV, Henderson DA Tularemia as a biological weapon: medical and public health management. JAMA. 2001 Jun 6;285(21):2763-73 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11386933
  8. ↑ Inglesby TV, Dennis DT, Henderson DA Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000 May 3;283(17):2281-90. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10807389
  9. ↑ Inglesby TV, O'Toole T, Henderson DA et al Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002 May 1;287(17):2236-52. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11980524
  10. ↑ Adalja AA, Toner E, Inglesby TV. Clinical Management of Potential Bioterrorism-Related Conditions. N Engl J Med. 2015 Mar 5;372(10):954-962. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25738671
  11. ↑ Bower WA et al Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. MMWR. Recommendations and Reports Dec 4, 2015 / 64(RR04);1-28 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6404a1.htm
  12. ↑ Christian MD. Biowarfare and bioterrorism. Crit Care Clin. 2013 Jul;29(3):717-56. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23830660
  13. ↑ Chung S, Baum CR, Nyquist AC DISASTER PREPAREDNESS ADVISORY COUNCIL, COUNCIL ON ENVIRONMENTAL HEALTH, COMMITTEE ON INFECTIOUS DISEASES. Chemical-Biological Terrorism and Its Impact on Children. Pediatrics. Jan 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31988169 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31988168 https://pediatrics.aappublications.org/content/early/2020/01/23/peds.2019-3749
    Technical report https://pediatrics.aappublications.org/content/early/2020/01/23/peds.2019-3750
  14. ↑ http://www.bt.cdc.gov
  15. ↑ 15.0 15.1 Bioterrorism and Complementary Alternative Medicine (CAM): What the Public Needs To Know http://nccam.nih.gov/health/alerts/bioterrorism/
Retrieved from "https://aaushi.info/w/index.php?title=A9320&oldid=1132427"